Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis

Chia Siang Kow, Syed Shahzad Hasan

Research output: Contribution to journalLetterpeer-review

3 Citations (Scopus)

Abstract

Globally, there have been close to 130 million reported cases of coronavirus disease 2019 (COVID-19) as of 2nd April 2021, with 2.8 million deaths documented [1]. In order to reduce the risk of mortality associated with COVID19, several drugs have been repurposed for its treatment.
Original languageEnglish
Pages (from-to)124-129
Number of pages6
JournalJournal of Thrombosis and Thrombolysis
Volume52
Issue number1
Early online date4 Apr 2021
DOIs
Publication statusPublished - 1 Jul 2021

Fingerprint

Dive into the research topics of 'Use of antiplatelet drugs and the risk of mortality in patients with COVID-19: a meta‐analysis'. Together they form a unique fingerprint.

Cite this